249 related articles for article (PubMed ID: 29203885)
41. Suppression of inflammatory signaling in monocytes from patients with coronary artery disease.
Schirmer SH; Fledderus JO; van der Laan AM; van der Pouw-Kraan TC; Moerland PD; Volger OL; Baggen JM; Böhm M; Piek JJ; Horrevoets AJ; van Royen N
J Mol Cell Cardiol; 2009 Feb; 46(2):177-85. PubMed ID: 19059264
[TBL] [Abstract][Full Text] [Related]
42. Blood monocyte heterogeneity and markers of endothelial activation in ankylosing spondylitis.
Surdacki A; Sulicka J; Korkosz M; Mikolajczyk T; Telesinska-Jasiówka D; Klimek E; Kierzkowska I; Guzik T; Grodzicki TK
J Rheumatol; 2014 Mar; 41(3):481-9. PubMed ID: 24488416
[TBL] [Abstract][Full Text] [Related]
43. Association of Elevations of Specific T Cell and Monocyte Subpopulations in Rheumatoid Arthritis With Subclinical Coronary Artery Atherosclerosis.
Winchester R; Giles JT; Nativ S; Downer K; Zhang HZ; Bag-Ozbek A; Zartoshti A; Bokhari S; Bathon JM
Arthritis Rheumatol; 2016 Jan; 68(1):92-102. PubMed ID: 26360530
[TBL] [Abstract][Full Text] [Related]
44. Immunosuppression and monocyte subsets.
Rogacev KS; Zawada AM; Hundsdorfer J; Achenbach M; Held G; Fliser D; Heine GH
Nephrol Dial Transplant; 2015 Jan; 30(1):143-53. PubMed ID: 25313167
[TBL] [Abstract][Full Text] [Related]
45. Elevated atherosclerosis-related gene expression, monocyte activation and microparticle-release are related to increased lipoprotein-associated oxidative stress in familial hypercholesterolemia.
Hjuler Nielsen M; Irvine H; Vedel S; Raungaard B; Beck-Nielsen H; Handberg A
PLoS One; 2015; 10(4):e0121516. PubMed ID: 25875611
[TBL] [Abstract][Full Text] [Related]
46. Predictors of Subclinical Inflammatory Obesity: Plasma Levels of Leptin, Very Low-Density Lipoprotein Cholesterol and CD14 Expression of CD16+ Monocytes.
Leite F; Leite Â; Santos A; Lima M; Barbosa J; Cosentino M; Ribeiro L
Obes Facts; 2017; 10(4):308-322. PubMed ID: 28738359
[TBL] [Abstract][Full Text] [Related]
47. Profiling of the three circulating monocyte subpopulations in human obesity.
Devêvre EF; Renovato-Martins M; Clément K; Sautès-Fridman C; Cremer I; Poitou C
J Immunol; 2015 Apr; 194(8):3917-23. PubMed ID: 25786686
[TBL] [Abstract][Full Text] [Related]
48. Lipoprotein apheresis influences monocyte subpopulations.
Jellinghaus S; Reich C; Schatz U; Tselmin S; Ibrahim K; Pfluecke C; Schauer A; Bornstein SR; Hohenstein B; Strasser RH; Julius U; Poitz DM
Atheroscler Suppl; 2017 Nov; 30():108-114. PubMed ID: 29096825
[TBL] [Abstract][Full Text] [Related]
49. The effect of statin therapy withdrawal on monocyte subsets.
Jaipersad AS; Shantsila E; Blann A; Lip GY
Eur J Clin Invest; 2013 Dec; 43(12):1307-13. PubMed ID: 24134608
[TBL] [Abstract][Full Text] [Related]
50. The Role of Different Monocyte Subsets in the Pathogenesis of Atherosclerosis and Acute Coronary Syndromes.
Idzkowska E; Eljaszewicz A; Miklasz P; Musial WJ; Tycinska AM; Moniuszko M
Scand J Immunol; 2015 Sep; 82(3):163-73. PubMed ID: 25997925
[TBL] [Abstract][Full Text] [Related]
51. Correlation Between High-Density Lipoprotein and Monocyte Subsets in Patients with Stable Coronary Heart Disease.
Jiang S; Li D; Li J; An Y
Med Sci Monit; 2015 Jun; 21():3129-35. PubMed ID: 26474031
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA profiling of human intermediate monocytes.
Zawada AM; Zhang L; Emrich IE; Rogacev KS; Krezdorn N; Rotter B; Fliser D; Devaux Y; Ziegler-Heitbrock L; Heine GH
Immunobiology; 2017 Mar; 222(3):587-596. PubMed ID: 27876379
[TBL] [Abstract][Full Text] [Related]
53. Expression of monocyte subsets and angiogenic markers in relation to carotid plaque neovascularization in patients with pre-existing coronary artery disease and carotid stenosis.
Jaipersad AS; Shantsila A; Lip GY; Shantsila E
Ann Med; 2014 Nov; 46(7):530-8. PubMed ID: 25012963
[TBL] [Abstract][Full Text] [Related]
54. Adipose-derived mesenchymal stem cells modulate CD14
Qiu G; Zheng G; Ge M; Huang L; Tong H; Chen P; Lai D; Hu Y; Cheng B; Shu Q; Xu J
Stem Cell Res Ther; 2017 Apr; 8(1):97. PubMed ID: 28446249
[TBL] [Abstract][Full Text] [Related]
55. Distinct scavenger receptor expression and function in the human CD14(+)/CD16(+) monocyte subset.
Draude G; von Hundelshausen P; Frankenberger M; Ziegler-Heitbrock HW; Weber C
Am J Physiol; 1999 Apr; 276(4):H1144-9. PubMed ID: 10199836
[TBL] [Abstract][Full Text] [Related]
56. Elevated markers of inflammation and endothelial activation and increased counts of intermediate monocytes in adult survivors of childhood acute lymphoblastic leukemia.
Sulicka J; Surdacki A; Mikołajczyk T; Strach M; Gryglewska B; Ćwiklińska M; Balwierz W; Guzik T; Grodzicki TK
Immunobiology; 2013 May; 218(5):810-6. PubMed ID: 23182707
[TBL] [Abstract][Full Text] [Related]
57. Monocyte heterogeneity in human cardiovascular disease.
Zawada AM; Rogacev KS; Schirmer SH; Sester M; Böhm M; Fliser D; Heine GH
Immunobiology; 2012 Dec; 217(12):1273-84. PubMed ID: 22898391
[TBL] [Abstract][Full Text] [Related]
58. Comparative gene expression analysis between coronary arteries and internal mammary arteries identifies a role for the TES gene in endothelial cell functions relevant to coronary artery disease.
Archacki SR; Angheloiu G; Moravec CS; Liu H; Topol EJ; Wang QK
Hum Mol Genet; 2012 Mar; 21(6):1364-73. PubMed ID: 22156939
[TBL] [Abstract][Full Text] [Related]
59. Monocyte subtypes predict clinical course and prognosis in human stroke.
Urra X; Villamor N; Amaro S; Gómez-Choco M; Obach V; Oleaga L; Planas AM; Chamorro A
J Cereb Blood Flow Metab; 2009 May; 29(5):994-1002. PubMed ID: 19293821
[TBL] [Abstract][Full Text] [Related]
60. Monocyte gene expression and coronary artery disease.
Maiwald S; Zwetsloot PP; Sivapalaratnam S; Dallinga-Thie GM
Curr Opin Clin Nutr Metab Care; 2013 Jul; 16(4):411-7. PubMed ID: 23739627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
